Skip to main content

Table 1 Patient demographics in the total study population and according to gender

From: Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study

Patient characteristics

Total

N = 100

Male

n = 58

Female

n = 42

Age, years

 Mean (SD)

67.7 (10.3)

68.1 (10.7)

67.1 (9.8)

 Median (range)

69 (38–90)

70 (38–89)

67.5 (49–90)

Age groups, years (n (%))

 ≤ 39

1 (1)

1 (2)

0 (0)

 40–49

3 (3)

1 (2)

2 (5)

 50–59

20 (20)

11 (19)

9 (21)

 60–69

28 (28)

15 (26)

13 (31)

 70–79

35 (35)

22 (38)

13 (31)

 80–89

12 (12)

8 (14)

4 (10)

 ≥ 90

1 (1)

0 (0)

1 (2)

ECOG performance statusa (n (%))

 0–1

85 (85)

46 (79)

39 (93)

 ≥ 2

15 (15)

12 (21)

3 (7)

R-ISS (n (%))b

 1

21 (21)

9 (16)

12 (29)

 2

49 (49)

31 (53)

18 (43)

 3

30 (30)

18 (31)

12 (29)

Co-morbidity

 Ischaemic heart disease

6 (6)

6 (10)

0

 Incompensated heart disease

6 (6)

6 (10)

0

 COL/chronic lung disease

3 (3)

3 (5)

0

 Asthma

0

0

0

 Rheumatoid arthritis

1 (1)

0

1 (2)

 Osteoarthritis

7 (7)

6 (10)

1 (2)

 Apoplexia/neurological disease

6 (6)

6 (10)

0

 Other

13 (13)

7 (12)

6 (14)

Bone disease

73 (73)

44 (76)

29 (69)

Bone disease with restriction for tests or exercisec

41 (41)e

23 (40)

18 (43)

Fracture (n (%))

33 (33)

19 (33)

14 (33)

 Non-vertebral fracture (n (%))

9 (9)

3 (5)

6 (14)

 Vertebral fracture (n (%))

24 (24)

16 (28)

8 (19)

Pain from non-vertebral fracture (n = 9)

5 (55)

0

5 (83)

 Mild

2 (22)

0

2 (33)

 Moderate

1 (11)

0

1 (17)

 Functional

2 (22)

0

2 (33)

Pain form vertebral fracture (n = 24)

19 (79)

13 (81)

6 (75)

 Mild

4 (17)

2 (13)

2 (25)

 Moderate

8 (33)

7 (44)

1 (13)

 Functional

7 (29)

4 (25)

3 (38)

Pain relieving drugs (n (%))

 None

45 (45)

28 (48)

17 (40)

 Non-opid/mildly pain relieving drugsd

31 (31)

14 (24)

17 (40)

 Moderately pain relieving drugse

11 (11)

6 (10)

5 (12)

 Strong pain relieving drugsf

13 (13)

10 (17)

3 (7)

Walking aid (n (%))

 Yes

17 (17)

9 (16)

8 (19)

 No

81 (81)

47 (81)

34 (81)

 Missing

2 (2)

2 (3)

0 (0)

Working (n (%))

 Yes

20 (20)

16 (28)

4 (10)

 No

78 (78)

40 (69)

38 (90)

 Missing

2 (2)

2 (3)

0 (0)

Working status (n (%))

 Working

20 (20)

16 (28)

4 (10)

 Retired

56 (56)

29 (50)

27 (64)

 Early retirement

3 (3)

1 (2)

2 (5)

 Off work sick, full time

14 (14)

8 (14)

6 (14)

 Un-employed

1 (1)

0 (0)

1 (2)

 On social security

1 (1)

0 (0)

1 (2)

 Other reason

2 (2)

1 (2)

1 (2)

 Missing

3 (3)

3 (5)

0 (0)

  1. aECOG Eastern Cooperative Oncology Group. bR-ISS Revised International Staging System. cthree participants had restrictions for the test part. dnon-opioid drugs. eopioid drugs but less or maximum equivalent to 20 mg morphine per day. efopioid drugs equivalent to more than 20 mg morphine per day